Prolonging Survival: The Role of Immune Checkpoint Inhibitors in the Treatment ofExtensive-StageSmall Cell Lung Cancer

Melosky, B; Cheema, PK; Brade, A; McLeod, D; Liu, G; Price, PW; Jao, K; Schellenberg, DD; Juergens, R; Leighl, N; Chu, Q

Melosky, B (corresponding author), British Columbia Canc Agcy, Vancouver Ctr, Med Oncol, 600 West 10th Ave, Vancouver, BC V5Z 4E6, Canada.

ONCOLOGIST, 2020; 25 (11): 981

Abstract

Background Small cell lung cancer (SCLC) represents approximately 15% of lung cancers, and approximately 70% are diagnosed as extensive-stage SCLC (ES......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索